- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05528003
Homemade Versus Commercialized Single-access Port Devices in Single-incision Laparoscopic Appendectomy
September 1, 2022 updated by: National Taiwan University Hospital
Comparison of Homemade Versus Commercialized Single-access Port Devices for Single-incision Laparoscopic Appendectomy: A Retrospective Comparative Study
Homemade and commercialized single-assess port devices are two kinds of port devices commonly used for single-incision laparoscopic appendectomy.
This study aimed to compare these two port devices in terms of short-term surgical outcomes and medical costs.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The advantages of homemade port devices include accessibility of the composites and lower equipment costs to the patients; however, the potential disadvantage is the easy leakage of CO2, ballooning of the surgical glove, and device instability, leading to difficult maneuverability.
On the other hand, commercialized port devices have relatively easy maneuverability, flexibility for instrument changes, and port stability for long-duration surgery ; however, their higher equipment cost is a disadvantage.
Study Type
Observational
Enrollment (Actual)
161
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Acute appendicitis patients
Description
Inclusion Criteria:
- The patients were diagnosed as acute appendicitis and undergoing single-incision laparoscopic appendectomy
Exclusion Criteria:
- The patient was not diagnosed as acute appendicitis based on surgical finding or pathological findings
- The patients underwent surgery other than single-incision laparoscopic surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Handmade single-access port device
The homemade single-access device was composed of a wound protector, sterile surgical glove, and three trocars inserted into and secured over three digits of the glove
|
|
Commercialized single-access port devices
Commercialized single-access port devices including GelPOINT® (Applied Medical, Rancho Santa Margarita, CA, USA) and LAGIPORT® (LAGIS, Taichung, Taiwan)
|
Two kinds of commercialized single-access port devices were used.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total surgical complications
Time Frame: Complications happened within 30 days
|
Complications were defined by Clavien-Dindo classification and comprehensive complication index.
|
Complications happened within 30 days
|
Superficial incisional surgical site infection (SSI)
Time Frame: Complications happened within 30 days
|
SSI was defined according to the American Centers for Disease Control and Prevention (CDC) classification
|
Complications happened within 30 days
|
Deep/organ SSI
Time Frame: Complications happened within 30 days
|
SSI was defined according to the American Centers for Disease Control and Prevention (CDC) classification
|
Complications happened within 30 days
|
Postoperative ileus
Time Frame: Complications happened within 30 days
|
Postoperative ileus was defined as the presence of symptoms and signs of abdominal distention, nausea, or vomiting combined with abdominal radiography, such as plain radiography or CT, within 30 days after SILA.
|
Complications happened within 30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Surgical time
Time Frame: Time from skin incision to application of gauzes
|
Total time needed for completing surgery
|
Time from skin incision to application of gauzes
|
Time to resume soft diet
Time Frame: The time to resume a soft diet was measured as the duration between the time leaving the recovery room and the time to resume a soft diet recorded in the nursing note.
|
Total time needed to resume bowel ability to resuming soft diet
|
The time to resume a soft diet was measured as the duration between the time leaving the recovery room and the time to resume a soft diet recorded in the nursing note.
|
Postoperative length of hospitalization
Time Frame: Postoperative LOH was defined as the duration between leaving the recovery room and discharge.
|
Total time to stay in hospital
|
Postoperative LOH was defined as the duration between leaving the recovery room and discharge.
|
Total medical costs
Time Frame: From the time patient being brought to emergency room to the time patient being discharged
|
Medical costs were defined as the medical fees paid by the National Health Insurance and did not include the self-paid equipment fees needed in SILA (e.g., commercialized single-access port devices, or wound protector).
|
From the time patient being brought to emergency room to the time patient being discharged
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yu-Tso LIAO, MD, NTUH, Hsin-Chu Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2013
Primary Completion (Actual)
April 30, 2022
Study Completion (Actual)
April 30, 2022
Study Registration Dates
First Submitted
August 31, 2022
First Submitted That Met QC Criteria
September 1, 2022
First Posted (Actual)
September 6, 2022
Study Record Updates
Last Update Posted (Actual)
September 6, 2022
Last Update Submitted That Met QC Criteria
September 1, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202104032RINB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Minimally Invasive Surgical Procedures
-
MedtronicRecruitingSurgical Procedures, Operative | Minimally Invasive Surgical ProceduresUnited States
-
Microline Surgical, Inc.AKRN Scientific Consulting, S.L.Active, not recruitingLaparoscopy | Minimally Invasive Surgical Procedures | Leakage of Cardiac DeviceSpain, Portugal
-
Szeged UniversityAlpha - Bio Tec Ltd.; dicomLAB Ltd.CompletedDental Implants | Surgery, Computer-Assisted | Minimally Invasive Surgical Procedures | Surgery, Oral | Dental Implantation, EndosseousHungary
-
Children's Hospital Medical Center, CincinnatiWithdrawnMinimally Invasive Fetoscopic Procedures
-
Xact Robotics Ltd.WithdrawnCT-guided Minimally Invasive Procedures e.g. BiopsiesUnited States, Israel
-
University GhentCatharina Ziekenhuis Eindhoven; Vlaamse Vereniging voor Obstetrie en Gynaecologie and other collaboratorsCompletedMyoma | Hysteroscopy | Uterine Septum | Polyp | Minimally Invasive Surgical Procedures | Placental Remnant | Adhesiolysis
-
Xact Robotics Ltd.CompletedCT-guided Minimally Invasive Procedures e.g., BiopsiesIsrael, United States
-
Mayo ClinicCompletedSurgical Procedures, Minimally Invasive | Blood Coagulation, DisordersUnited States
-
Dr.Gerhard KaufmannCompletedHallux Valgus | Minimally Invasive Surgical ProceduresAustria
-
Bengt NovikUppsala University; Swedish Hernia Registry; Skaraborg Hospital Research & Development...CompletedRecurrence | Hernia | Hernia, Inguinal | Laparoscopy | Hernia, Femoral | Surgical Mesh | Fixation Device; Complications | Surgical Procedures, Minimally Invasive | Surgical Staplers
Clinical Trials on Commercialized single-access port devices
-
North Tees and Hartlepool NHS Foundation TrustUnknownColorectal Cancer | Inflammatory Bowel Disease | Diverticular Disease | Benign Colorectal NeoplasmUnited Kingdom
-
University of CagliariUnknown
-
Cendres+MétauxTerminatedHemodialysis Access Failure (Disorder) | End-Stage Renal Disease Requiring HaemodialysisSwitzerland
-
IRCCS Sacro Cuore Don Calabria di NegrarUnknown
-
The Catholic University of KoreaCompletedPostoperative Pain | Uterine Disease
-
B.Braun Médical - CoE ChasseneuilNot yet recruitingThe Performance / Safety of the Celsite® Venous Access Ports
-
Chang Gung Memorial HospitalCompleted
-
Perouse MedicalEclevar MedtechCompletedChemotherapy | Antibiotics | Parenteral Nutrition | Venous Access | Venous System | Antiviral | Transfusion BloodFrance
-
Asan Medical CenterCompletedBenign or Preinvasive Uterine DiseaseKorea, Republic of
-
Rambam Health Care CampusCompletedPelvic Organ ProlapseIsrael